Researcher Sponsored Research 2024-3

Through this call, research studies will be funded in which the researcher or his or her organization is the promoter of the study, of a preclinical or clinical nature, and in which Pfizer provides financial and/or non-financial support for the study. development or refinement of specific and defined medical knowledge related to a Pfizer asset.

Areas of interest:

• Oncology.
• Rare diseases.
• Vaccines and antivirals.
• Inflammation and immunology.
• Internal Medicine.
• Antiinfectives.

Requirements

Applicants must be researchers or organizations from around the world.

Deadline: August 25, 2024.